Kit S, Sheppard M, Ichimura H, Nusinoff-Lehrman S, Ellis M N, Fyfe J A, Otsuka H
Division of Biochemical Virology, Baylor College of Medicine, Houston, Texas 77030.
Antimicrob Agents Chemother. 1987 Oct;31(10):1483-90. doi: 10.1128/AAC.31.10.1483.
To identify the nucleotide changes that occur in drug-induced thymidine kinase (TK) mutants of herpes simplex virus type 2 (HSV-2), we compared the nucleotide sequences of the tk genes of two mutant HSV-2 clones isolated from a patient who had been treated with acyclovir [9-(2-hydroxyethoxymethyl)guanine; ACV] with the nucleotide sequence of the parental TK+ HSV-2(8703) strain isolated from the same patient. One of the mutants, TK-altered (TKA) HSV-2(9637), was ACV resistant but induced the incorporation of [14C]thymidine into the DNA of infected rabbit skin cells. The nucleotide sequence of the tk gene of mutant TKA HSV-2(9637) had a single change (G to A) at nucleotide 668, which would cause an arginine-to-histidine substitution at amino acid residue 223 of the TK polypeptide. The second ACV-resistant mutant, TK- HSV-2(8710), did not induce detectable incorporation of [14C]thymidine into the DNA of infected rabbit skin cells. This mutant exhibited a deletion of a single base at nucleotide 217 of its nucleotide sequence. This deletion would cause a frameshift mutation at amino acid residue 73 and chain termination at amino acid residue 86 of the TK polypeptide. The nucleotide sequence of TK+ HSV-2(8703) was the same as that of the laboratory strain, TK+ HSV-2(333). The nucleotide sequence of a bromodeoxyuridine-resistant TK- HSV-2(333) mutant of TK+ HSV-2(333) also exhibited a single-base deletion, but at nucleotide 439. This deletion would cause a frameshift mutation at amino acid residue 147 and chain termination at amino acid residue 182. The frameshift mutations of TK- HSV(8710) and TK- HSV-2(333), respectively, occurred in sequences in which C was repeated three times and G was repeated seven times. The results raise the possibility that TK- frameshift mutations of HSV-2 may be common.
为了鉴定在2型单纯疱疹病毒(HSV-2)的药物诱导胸苷激酶(TK)突变体中发生的核苷酸变化,我们比较了从一名接受过阿昔洛韦[9-(2-羟乙氧甲基)鸟嘌呤;ACV]治疗的患者中分离出的两个突变HSV-2克隆的tk基因的核苷酸序列,与从同一患者中分离出的亲代TK+ HSV-2(8703)株的核苷酸序列。其中一个突变体,TK改变(TKA)HSV-2(9637),对ACV耐药,但能诱导[14C]胸苷掺入感染的兔皮肤细胞的DNA中。突变体TKA HSV-2(9637)的tk基因的核苷酸序列在核苷酸668处有一个单一变化(G到A),这将导致TK多肽的氨基酸残基223处的精氨酸被组氨酸取代。第二个对ACV耐药的突变体,TK- HSV-2(8710),不能诱导[14C]胸苷掺入感染的兔皮肤细胞的DNA中。该突变体在其核苷酸序列的核苷酸217处表现出一个单碱基缺失。这种缺失将导致TK多肽的氨基酸残基73处发生移码突变,并在氨基酸残基86处发生链终止。TK+ HSV-2(8703)的核苷酸序列与实验室菌株TK+ HSV-2(333)的相同。TK+ HSV-2(333)的一个耐溴脱氧尿苷的TK- HSV-2(333)突变体的核苷酸序列也表现出一个单碱基缺失,但在核苷酸439处。这种缺失将导致氨基酸残基147处发生移码突变,并在氨基酸残基182处发生链终止。TK- HSV(8710)和TK- HSV-2(333)的移码突变分别发生在C重复三次和G重复七次的序列中。结果增加了HSV-2的TK-移码突变可能很常见的可能性。